Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
373.85 EUR | -2.20% |
|
+1.05% | +9.36% |
07-09 | Enorama Pharma Appoints New Commercial Director - Takes Office in September | FW |
07-09 | L'ORÉAL : UBS still on hold ahead of quarterly results | CF |
Capitalization | 200B 234B 186B 173B 320B 20,044B 355B 2,229B 852B 9,385B 876B 858B 34,424B | P/E ratio 2025 * |
30.1x | P/E ratio 2026 * | 27.6x |
---|---|---|---|---|---|
Enterprise value | 199B 233B 186B 173B 319B 19,996B 355B 2,224B 850B 9,363B 874B 856B 34,342B | EV / Sales 2025 * |
4.47x | EV / Sales 2026 * | 4.23x |
Free-Float |
42.92% | Yield 2025 * |
1.9% | Yield 2026 * | 2.06% |
More valuation ratios
* Estimated data
More news
Last Transcript: L'Oréal
More press releases
1 day | -2.20% | ||
1 week | +1.05% | ||
Current month | +2.96% | ||
1 month | -0.51% | ||
3 months | +7.55% | ||
6 months | +14.19% | ||
Current year | +9.36% |
1 week | 367.15 | ![]() | 382.75 |
1 month | 348.35 | ![]() | 382.75 |
Current year | 323.7 | ![]() | 394.68 |
1 year | 316.3 | ![]() | 413.2 |
3 years | 300.7 | ![]() | 461.85 |
5 years | 269.3 | ![]() | 461.85 |
10 years | 140.4 | ![]() | 461.85 |
Manager | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 61 | 2021-04-30 | |
Director of Finance/CFO | 59 | 2019-02-07 | |
Antoine Vanlaeys
COO | Chief Operating Officer | - | 2021-01-31 |
Director | Title | Age | Since |
---|---|---|---|
Jean-Paul Agon
CHM | Chairman | 69 | 2011-02-28 |
Director/Board Member | 61 | 2021-04-30 | |
Director/Board Member | 39 | 2012-02-12 |
Name | Weight | AuM | 1st Jan change | |
---|---|---|---|---|
3.45% | 21 M€ | +4.23% | - | |
3.22% | 137 M€ | +12.80% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-2.20% | +1.05% | -9.39% | +10.33% | 234B | ||
-1.80% | +6.82% | +70.50% | - | 37.35B | ||
+0.47% | +3.86% | -2.30% | +13.86% | 20.79B | ||
+3.41% | -0.72% | -44.38% | -53.39% | 7.07B | ||
-2.78% | -0.60% | -14.21% | +2.15% | 5.98B | ||
-0.22% | +2.12% | -23.09% | -24.46% | 4.55B | ||
-1.17% | -0.59% | -51.53% | -32.89% | 4.41B | ||
-0.64% | -2.11% | +4.78% | +90.96% | 4.36B | ||
-1.73% | +1.35% | +94.81% | - | 4.19B | ||
-2.76% | -6.31% | +68.97% | - | 3.97B | ||
Average | -0.94% | -0.14% | +9.42% | +0.94% | 32.63B | |
Weighted average by Cap. | -1.81% | +2.58% | +1.08% | +8.82% |
2025 * | 2026 * | |
---|---|---|
Net sales | 44.55B 52.1B 41.5B 38.6B 71.32B 4,471B 79.26B 497B 190B 2,093B 195B 191B 7,678B | 46.54B 54.43B 43.35B 40.32B 74.51B 4,670B 82.8B 519B 199B 2,187B 204B 200B 8,021B |
Net income | 6.67B 7.8B 6.21B 5.78B 10.67B 669B 11.86B 74.42B 28.45B 313B 29.25B 28.64B 1,149B | 7.23B 8.46B 6.74B 6.27B 11.58B 726B 12.87B 80.73B 30.87B 340B 31.73B 31.07B 1,247B |
Net Debt | -472M -552M -440M -409M -755M -47.35B -839M -5.27B -2.01B -22.17B -2.07B -2.03B -81.32B | -3.07B -3.59B -2.86B -2.66B -4.91B -308B -5.46B -34.24B -13.09B -144B -13.46B -13.18B -529B |
More financial data
* Estimated data
Employees
94,397
Sector
Personal Products
Calendar
Date | Price | Change | Volume |
---|---|---|---|
25-07-11 | 373.85 € | -2.20% | 211,268 |
25-07-10 | 382.25 € | +2.11% | 286,165 |
25-07-09 | 374.35 € | +0.09% | 308,300 |
25-07-08 | 374.00 € | +0.34% | 273,327 |
25-07-07 | 372.75 € | +0.76% | 238,536 |
Real-time Euronext Paris, July 11, 2025 at 11:55 am
More quotesSell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
373.85EUR
Average target price
382.28EUR
Spread / Average Target
+2.25%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- OR Stock
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition